RNA Analysis/Transcriptomics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
RNA Analysis/Transcriptomics is the study of RNA transcripts outturned by genome of any organism, under specific circumstances or in a specific cell using high throughput methods. Comparison of transcriptomes enables in identifying genes that are differentially expressed in distinct cell populations, or in response to different treatments.
MARKET SCOPE
The "Global RNA Analysis/Transcriptomics Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the RNA analysis/transcriptomics market with detailed market segmentation by product, technology, application, end user and geography. The report provides key statistics on the market status of the leading RNA analysis/transcriptomics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product, the global RNA Analysis/Transcriptomics market is segmented into consumables, instruments, software and services.
- The technology segment is classified into microarray, real-time quantitative polymerase chain reaction, and sequencing technologies.
- Based on application the market is segmented into diagnostics and disease profiling, drug discovery and others.
- Based on end user the market is segmented into government institutes and academic centers, pharmaceutical and biotechnological companies and contract research organization.
MARKET DYNAMICS
Drivers:
- Increasing advancements in the field of transcriptomics such as advancements in RNA-sequencing technology
- Growth in transcriptomics application
- Increasing funding by various private and government organization
- Increasing number of pharmaceutical and biotechnology companies
- Continuous improvements in the healthcare infrastructure.
Restraints:
- Dearth of skilled professionals
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The RNA analysis/transcriptomics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the RNA analysis/transcriptomics market in these regions.
IMPACT OF COVID-19 ON RNA ANALYSIS/TRANSCRIPTOMICS MARKET
All countries across the globe have been highly affected due to the outbreak of the COVID-19 pandemic. Countries such as the US and Canada reported the highest numbers of COVID-19 positive cases. The US-registered highest number of deaths due to the COVID-19 pandemic. The chaotic situation was created in the medical industry across the countries, increased demand for COVID diagnostics and therapeutics have dramatically increased in the hospitals.
The COVID-19 pandemic has negatively impacted all phases of drug development and forced many pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold.
Further in North America, the COVID-19 pandemic has disrupted scientific research activities significantly. Research Laboratories have been forced to shut down. Researchers have been advised to work from home. Animal facilities have been scaled down and shipping of research supplies has been delayed.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The RNA analysis/transcriptomics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the RNA analysis/transcriptomics market in these regions.
IMPACT OF COVID-19 ON RNA ANALYSIS/TRANSCRIPTOMICS MARKET
All countries across the globe have been highly affected due to the outbreak of the COVID-19 pandemic. Countries such as the US and Canada reported the highest numbers of COVID-19 positive cases. The US-registered highest number of deaths due to the COVID-19 pandemic. The chaotic situation was created in the medical industry across the countries, increased demand for COVID diagnostics and therapeutics have dramatically increased in the hospitals.
The COVID-19 pandemic has negatively impacted all phases of drug development and forced many pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold.
Further in North America, the COVID-19 pandemic has disrupted scientific research activities significantly. Research Laboratories have been forced to shut down. Researchers have been advised to work from home. Animal facilities have been scaled down and shipping of research supplies has been delayed.
MARKET PLAYERS
The report covers key developments in the RNA analysis/transcriptomics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from RNA analysis/transcriptomics market are anticipated to lucrative growth opportunities in the future with the rising demand for RNA analysis/transcriptomics in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the RNA analysis/transcriptomics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Bio-Rad Laboratories Inc.
- Illumina Inc.
- GE Healthcare
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies Inc.
- Thermofisher Scientific Inc.
- Sigma Aldrich
- Qiagen N.V.
- Affymetrix Inc.
- Fluidigm Corporation
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 RNA Analysis And Transcriptomics Market - By Product
1.3.2 RNA Analysis And Transcriptomics Market - By Technology
1.3.3 RNA Analysis And Transcriptomics Market - By Application
1.3.4 RNA Analysis And Transcriptomics Market - By End User
1.3.5 RNA Analysis And Transcriptomics Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RNA ANALYSIS AND TRANSCRIPTOMICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RNA ANALYSIS AND TRANSCRIPTOMICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RNA ANALYSIS AND TRANSCRIPTOMICS MARKET - GLOBAL MARKET ANALYSIS
6.1. RNA ANALYSIS AND TRANSCRIPTOMICS - GLOBAL MARKET OVERVIEW
6.2. RNA ANALYSIS AND TRANSCRIPTOMICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. RNA ANALYSIS AND TRANSCRIPTOMICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CONSUMABLES
7.3.1. Overview
7.3.2. Consumables Market Forecast and Analysis
7.4. INSTRUMENTS
7.4.1. Overview
7.4.2. Instruments Market Forecast and Analysis
7.5. SOFTWARE
7.5.1. Overview
7.5.2. Software Market Forecast and Analysis
7.6. SERVICES
7.6.1. Overview
7.6.2. Services Market Forecast and Analysis
8. RNA ANALYSIS AND TRANSCRIPTOMICS MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. MICROARRAY
8.3.1. Overview
8.3.2. Microarray Market Forecast and Analysis
8.4. REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION
8.4.1. Overview
8.4.2. Real-Time Quantitative Polymerase Chain Reaction Market Forecast and Analysis
8.5. SEQUENCING TECHNOLOGIES
8.5.1. Overview
8.5.2. Sequencing Technologies Market Forecast and Analysis
9. RNA ANALYSIS AND TRANSCRIPTOMICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. DIAGNOSTICS AND DISEASE PROFILING
9.3.1. Overview
9.3.2. Diagnostics and Disease Profiling Market Forecast and Analysis
9.4. DRUG DISCOVERY
9.4.1. Overview
9.4.2. Drug Discovery Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. RNA ANALYSIS AND TRANSCRIPTOMICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. GOVERNMENT INSTITUTES AND ACADEMIC CENTERS
10.3.1. Overview
10.3.2. Government Institutes and Academic Centers Market Forecast and Analysis
10.4. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
10.4.1. Overview
10.4.2. Pharmaceutical and Biotechnological Companies Market Forecast and Analysis
10.5. CONTRACT RESEARCH ORGANIZATION
10.5.1. Overview
10.5.2. Contract Research Organization Market Forecast and Analysis
11. RNA ANALYSIS AND TRANSCRIPTOMICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America RNA Analysis And Transcriptomics Market Overview
11.1.2 North America RNA Analysis And Transcriptomics Market Forecasts and Analysis
11.1.3 North America RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Product
11.1.4 North America RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Technology
11.1.5 North America RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Application
11.1.6 North America RNA Analysis And Transcriptomics Market Forecasts and Analysis - By End User
11.1.7 North America RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Countries
11.1.7.1 United States RNA Analysis And Transcriptomics Market
11.1.7.1.1 United States RNA Analysis And Transcriptomics Market by Product
11.1.7.1.2 United States RNA Analysis And Transcriptomics Market by Technology
11.1.7.1.3 United States RNA Analysis And Transcriptomics Market by Application
11.1.7.1.4 United States RNA Analysis And Transcriptomics Market by End User
11.1.7.2 Canada RNA Analysis And Transcriptomics Market
11.1.7.2.1 Canada RNA Analysis And Transcriptomics Market by Product
11.1.7.2.2 Canada RNA Analysis And Transcriptomics Market by Technology
11.1.7.2.3 Canada RNA Analysis And Transcriptomics Market by Application
11.1.7.2.4 Canada RNA Analysis And Transcriptomics Market by End User
11.1.7.3 Mexico RNA Analysis And Transcriptomics Market
11.1.7.3.1 Mexico RNA Analysis And Transcriptomics Market by Product
11.1.7.3.2 Mexico RNA Analysis And Transcriptomics Market by Technology
11.1.7.3.3 Mexico RNA Analysis And Transcriptomics Market by Application
11.1.7.3.4 Mexico RNA Analysis And Transcriptomics Market by End User
11.2. EUROPE
11.2.1 Europe RNA Analysis And Transcriptomics Market Overview
11.2.2 Europe RNA Analysis And Transcriptomics Market Forecasts and Analysis
11.2.3 Europe RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Product
11.2.4 Europe RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Technology
11.2.5 Europe RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Application
11.2.6 Europe RNA Analysis And Transcriptomics Market Forecasts and Analysis - By End User
11.2.7 Europe RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany RNA Analysis And Transcriptomics Market
11.2.7.1.1 Germany RNA Analysis And Transcriptomics Market by Product
11.2.7.1.2 Germany RNA Analysis And Transcriptomics Market by Technology
11.2.7.1.3 Germany RNA Analysis And Transcriptomics Market by Application
11.2.7.1.4 Germany RNA Analysis And Transcriptomics Market by End User
11.2.7.2 France RNA Analysis And Transcriptomics Market
11.2.7.2.1 France RNA Analysis And Transcriptomics Market by Product
11.2.7.2.2 France RNA Analysis And Transcriptomics Market by Technology
11.2.7.2.3 France RNA Analysis And Transcriptomics Market by Application
11.2.7.2.4 France RNA Analysis And Transcriptomics Market by End User
11.2.7.3 Italy RNA Analysis And Transcriptomics Market
11.2.7.3.1 Italy RNA Analysis And Transcriptomics Market by Product
11.2.7.3.2 Italy RNA Analysis And Transcriptomics Market by Technology
11.2.7.3.3 Italy RNA Analysis And Transcriptomics Market by Application
11.2.7.3.4 Italy RNA Analysis And Transcriptomics Market by End User
11.2.7.4 Spain RNA Analysis And Transcriptomics Market
11.2.7.4.1 Spain RNA Analysis And Transcriptomics Market by Product
11.2.7.4.2 Spain RNA Analysis And Transcriptomics Market by Technology
11.2.7.4.3 Spain RNA Analysis And Transcriptomics Market by Application
11.2.7.4.4 Spain RNA Analysis And Transcriptomics Market by End User
11.2.7.5 United Kingdom RNA Analysis And Transcriptomics Market
11.2.7.5.1 United Kingdom RNA Analysis And Transcriptomics Market by Product
11.2.7.5.2 United Kingdom RNA Analysis And Transcriptomics Market by Technology
11.2.7.5.3 United Kingdom RNA Analysis And Transcriptomics Market by Application
11.2.7.5.4 United Kingdom RNA Analysis And Transcriptomics Market by End User
11.2.7.6 Rest of Europe RNA Analysis And Transcriptomics Market
11.2.7.6.1 Rest of Europe RNA Analysis And Transcriptomics Market by Product
11.2.7.6.2 Rest of Europe RNA Analysis And Transcriptomics Market by Technology
11.2.7.6.3 Rest of Europe RNA Analysis And Transcriptomics Market by Application
11.2.7.6.4 Rest of Europe RNA Analysis And Transcriptomics Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific RNA Analysis And Transcriptomics Market Overview
11.3.2 Asia-Pacific RNA Analysis And Transcriptomics Market Forecasts and Analysis
11.3.3 Asia-Pacific RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific RNA Analysis And Transcriptomics Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia RNA Analysis And Transcriptomics Market
11.3.7.1.1 Australia RNA Analysis And Transcriptomics Market by Product
11.3.7.1.2 Australia RNA Analysis And Transcriptomics Market by Technology
11.3.7.1.3 Australia RNA Analysis And Transcriptomics Market by Application
11.3.7.1.4 Australia RNA Analysis And Transcriptomics Market by End User
11.3.7.2 China RNA Analysis And Transcriptomics Market
11.3.7.2.1 China RNA Analysis And Transcriptomics Market by Product
11.3.7.2.2 China RNA Analysis And Transcriptomics Market by Technology
11.3.7.2.3 China RNA Analysis And Transcriptomics Market by Application
11.3.7.2.4 China RNA Analysis And Transcriptomics Market by End User
11.3.7.3 India RNA Analysis And Transcriptomics Market
11.3.7.3.1 India RNA Analysis And Transcriptomics Market by Product
11.3.7.3.2 India RNA Analysis And Transcriptomics Market by Technology
11.3.7.3.3 India RNA Analysis And Transcriptomics Market by Application
11.3.7.3.4 India RNA Analysis And Transcriptomics Market by End User
11.3.7.4 Japan RNA Analysis And Transcriptomics Market
11.3.7.4.1 Japan RNA Analysis And Transcriptomics Market by Product
11.3.7.4.2 Japan RNA Analysis And Transcriptomics Market by Technology
11.3.7.4.3 Japan RNA Analysis And Transcriptomics Market by Application
11.3.7.4.4 Japan RNA Analysis And Transcriptomics Market by End User
11.3.7.5 South Korea RNA Analysis And Transcriptomics Market
11.3.7.5.1 South Korea RNA Analysis And Transcriptomics Market by Product
11.3.7.5.2 South Korea RNA Analysis And Transcriptomics Market by Technology
11.3.7.5.3 South Korea RNA Analysis And Transcriptomics Market by Application
11.3.7.5.4 South Korea RNA Analysis And Transcriptomics Market by End User
11.3.7.6 Rest of Asia-Pacific RNA Analysis And Transcriptomics Market
11.3.7.6.1 Rest of Asia-Pacific RNA Analysis And Transcriptomics Market by Product
11.3.7.6.2 Rest of Asia-Pacific RNA Analysis And Transcriptomics Market by Technology
11.3.7.6.3 Rest of Asia-Pacific RNA Analysis And Transcriptomics Market by Application
11.3.7.6.4 Rest of Asia-Pacific RNA Analysis And Transcriptomics Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa RNA Analysis And Transcriptomics Market Overview
11.4.2 Middle East and Africa RNA Analysis And Transcriptomics Market Forecasts and Analysis
11.4.3 Middle East and Africa RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa RNA Analysis And Transcriptomics Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa RNA Analysis And Transcriptomics Market
11.4.7.1.1 South Africa RNA Analysis And Transcriptomics Market by Product
11.4.7.1.2 South Africa RNA Analysis And Transcriptomics Market by Technology
11.4.7.1.3 South Africa RNA Analysis And Transcriptomics Market by Application
11.4.7.1.4 South Africa RNA Analysis And Transcriptomics Market by End User
11.4.7.2 Saudi Arabia RNA Analysis And Transcriptomics Market
11.4.7.2.1 Saudi Arabia RNA Analysis And Transcriptomics Market by Product
11.4.7.2.2 Saudi Arabia RNA Analysis And Transcriptomics Market by Technology
11.4.7.2.3 Saudi Arabia RNA Analysis And Transcriptomics Market by Application
11.4.7.2.4 Saudi Arabia RNA Analysis And Transcriptomics Market by End User
11.4.7.3 U.A.E RNA Analysis And Transcriptomics Market
11.4.7.3.1 U.A.E RNA Analysis And Transcriptomics Market by Product
11.4.7.3.2 U.A.E RNA Analysis And Transcriptomics Market by Technology
11.4.7.3.3 U.A.E RNA Analysis And Transcriptomics Market by Application
11.4.7.3.4 U.A.E RNA Analysis And Transcriptomics Market by End User
11.4.7.4 Rest of Middle East and Africa RNA Analysis And Transcriptomics Market
11.4.7.4.1 Rest of Middle East and Africa RNA Analysis And Transcriptomics Market by Product
11.4.7.4.2 Rest of Middle East and Africa RNA Analysis And Transcriptomics Market by Technology
11.4.7.4.3 Rest of Middle East and Africa RNA Analysis And Transcriptomics Market by Application
11.4.7.4.4 Rest of Middle East and Africa RNA Analysis And Transcriptomics Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America RNA Analysis And Transcriptomics Market Overview
11.5.2 South and Central America RNA Analysis And Transcriptomics Market Forecasts and Analysis
11.5.3 South and Central America RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Product
11.5.4 South and Central America RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Technology
11.5.5 South and Central America RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Application
11.5.6 South and Central America RNA Analysis And Transcriptomics Market Forecasts and Analysis - By End User
11.5.7 South and Central America RNA Analysis And Transcriptomics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil RNA Analysis And Transcriptomics Market
11.5.7.1.1 Brazil RNA Analysis And Transcriptomics Market by Product
11.5.7.1.2 Brazil RNA Analysis And Transcriptomics Market by Technology
11.5.7.1.3 Brazil RNA Analysis And Transcriptomics Market by Application
11.5.7.1.4 Brazil RNA Analysis And Transcriptomics Market by End User
11.5.7.2 Argentina RNA Analysis And Transcriptomics Market
11.5.7.2.1 Argentina RNA Analysis And Transcriptomics Market by Product
11.5.7.2.2 Argentina RNA Analysis And Transcriptomics Market by Technology
11.5.7.2.3 Argentina RNA Analysis And Transcriptomics Market by Application
11.5.7.2.4 Argentina RNA Analysis And Transcriptomics Market by End User
11.5.7.3 Rest of South and Central America RNA Analysis And Transcriptomics Market
11.5.7.3.1 Rest of South and Central America RNA Analysis And Transcriptomics Market by Product
11.5.7.3.2 Rest of South and Central America RNA Analysis And Transcriptomics Market by Technology
11.5.7.3.3 Rest of South and Central America RNA Analysis And Transcriptomics Market by Application
11.5.7.3.4 Rest of South and Central America RNA Analysis And Transcriptomics Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RNA ANALYSIS AND TRANSCRIPTOMICS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. RNA ANALYSIS AND TRANSCRIPTOMICS MARKET, KEY COMPANY PROFILES
14.1. BIO-RAD LABORATORIES INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ILLUMINA INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. GE HEALTHCARE
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. F. HOFFMANN-LA ROCHE LTD.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. AGILENT TECHNOLOGIES INC.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. THERMOFISHER SCIENTIFIC INC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. SIGMA ALDRICH
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. QIAGEN N.V
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. AFFYMETRIX INC.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. FLUIDIGM CORPORATION
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. BioRad Laboratories Inc.
2. Illumina Inc.
3. GE Healthcare
4. F. HoffmannLa Roche Ltd.
5. Agilent Technologies Inc.
6. Thermofisher Scientific Inc.
7. Sigma Aldrich
8. Qiagen N.V.
9. Affymetrix Inc.
10. Fluidigm Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For